The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

KYMR FINANCIAL STATEMENTS

Kymera Therapeutics Inc — balance sheet, income statement and cash flow trends

KYMRKymera Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue105 M $Gross Profit107.1 M $ · 102%Operating Income-350.2 M $ · -334%Pre-tax Income-299.9 M $ · -286%Net Income to Owners-299.7 M $ · -285%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue105 M $+134.8%
Gross Profit107.1 M $+151.2%
Operating Income-350.2 M $—
EBITDA-292.8 M $—
Net Income to Owners-299.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.6 B
  • Equity1.5 B $92%
  • Current Liabilities75 M $5%
  • Long-term Liabilities64.9 M $4%

Key Figures

YoY change
Total Assets1.6 B $+45.5%
Total Liabilities139.9 M $-12.4%
Total Equity1.5 B $+55.4%
Cash & ST Investments691 M $+3.8%
Total Debt82.2 M $-4.1%
Net Debt-42.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-1 B-500 M0-236.8 M $Operating-752.5 M $Investing777.9 M $Financing-211.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-236.8 M $—
Capital Expenditures1.2 M $-47.8%
Free Cash Flow-238 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on KYMR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.